Alternatives to Cellbricks Therapeutics

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing advanced vision restoration technology through a retinal implant.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing novel therapies to reverse aging and extend lifespan.

Developing lightweight bionic technology.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing epigenetic reprogramming drugs for age restoration.

Developing soft, stretchable brain-computer interface platforms.

Developing novel male contraceptives.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and distributes bioreactor technology for stem cell cultivation.

Elevating uterine health through innovative biomaterial therapies.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

Cultivating wood directly into its final shape, 10,000x faster than forestry.

Developing breath-based diagnostics for lung diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Enzyme-based technology to break down alcohol in the stomach.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A global leader in clinical pharmacology and bioanalytical sciences.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A leading organization dedicated to curing and treating cystic fibrosis.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.